What Does a Positive HLA-B27 Mean?
A positive HLA-B27 result often causes understandable concern. Many people have the test because of persistent back pain, stiffness, joint symptoms or a possible inflammatory condition. When the result is positive, the obvious question is whether this confirms ankylosing spondylitis or another form of inflammatory arthritis.
The short answer is no.
HLA-B27 can be an important diagnostic clue, but it is not a diagnosis. Its significance depends on why the test was requested and whether the result fits with the symptoms, examination and any other relevant findings.
Many people with HLA-B27 never develop inflammatory disease. Conversely, some people with genuine spondyloarthritis are HLA-B27 negative.
What is HLA-B27?
HLA-B27 is an inherited variant of a protein involved in the regulation of the immune system. The letters HLA stand for human leukocyte antigen.
HLA proteins are found on the surface of cells and help the immune system distinguish the body’s own cells from foreign material. HLA-B27 is one particular variant within this system.
The result is inherited and normally remains the same throughout life. It does not become more strongly or weakly positive, and it does not need to be monitored or routinely repeated.
HLA-B27 is associated with a family of inflammatory conditions called spondyloarthritis. The strongest association is with axial spondyloarthritis, which includes ankylosing spondylitis.
Association does not mean certainty. Most people who carry HLA-B27 do not develop axial spondyloarthritis or another inflammatory rheumatic disease.
Does a positive HLA-B27 mean ankylosing spondylitis?
No. A positive test does not confirm ankylosing spondylitis or axial spondyloarthritis.
The result increases the likelihood of spondyloarthritis when someone already has a suggestive clinical history. If that history is absent, HLA-B27 may simply be an incidental inherited finding.
For example, the test is more relevant in someone whose back pain began before the age of 45, has persisted for more than three months, is worse after rest and improves with movement. Pain that wakes someone during the second half of the night, prolonged morning stiffness and alternating buttock pain can also increase suspicion.
The result carries more weight when these symptoms occur alongside psoriasis, inflammatory bowel disease, recurrent uveitis, unexplained enthesitis or dactylitis.
By contrast, a positive result in someone with short-lived or clearly mechanical back pain may have little clinical significance.
Which conditions are associated with HLA-B27?
HLA-B27 is most strongly associated with axial spondyloarthritis and ankylosing spondylitis. It can also be relevant in reactive arthritis, some forms of psoriatic arthritis and arthritis associated with Crohn’s disease or ulcerative colitis.
Acute anterior uveitis is another important association. Uveitis is inflammation inside the eye rather than a type of arthritis, but it can occur as part of the same wider inflammatory pattern.
HLA-B27 is not equally important in every person with psoriasis, bowel disease or joint pain. It becomes useful when it helps connect several otherwise separate clinical features.
What symptoms make the result more significant?
A positive HLA-B27 is most informative when there is evidence of a possible spondyloarthritis pattern.
Back pain is more suggestive when it began relatively young, has lasted for several months, improves with activity rather than rest and is associated with significant morning stiffness or night pain.
Other relevant features include persistent heel pain from enthesitis, swelling of a whole finger or toe known as dactylitis, recurrent joint swelling, psoriasis or psoriatic nail changes. A history of Crohn’s disease, ulcerative colitis or a close relative with spondyloarthritis can also increase the likelihood that the result is relevant.
These features do not individually prove a diagnosis. Their importance lies in the pattern they form together.
Is HLA-B27 dangerous?
HLA-B27 is not dangerous in itself. It does not damage the body simply because it is present, and there is no treatment aimed at removing or suppressing the marker.
If someone is HLA-B27 positive but has no symptoms suggestive of inflammatory disease, treatment and routine rheumatology monitoring are not usually required.
The marker is relevant only because it changes the probability of certain inflammatory conditions when the clinical features fit. It should not be treated as a diagnosis waiting to happen.
Is HLA-B27 inherited?
Yes. HLA-B27 is inherited genetically, which means it can occur in more than one member of a family.
However, inheriting HLA-B27 is not the same as inheriting ankylosing spondylitis. Most people with the marker remain well.
Relatives do not ordinarily need to be tested simply because one family member is positive. Testing is most useful when the person being tested has symptoms or associated features that create a genuine suspicion of spondyloarthritis.
Testing healthy relatives without a clinical reason may create anxiety without changing medical care.
Is HLA-B27 a screening test?
No. HLA-B27 should not be used as a general screening test for back pain or arthritis.
Back pain is extremely common, while axial spondyloarthritis is much less common. Testing everyone with back pain would therefore identify many healthy HLA-B27 carriers whose pain has an unrelated mechanical cause.
The test is most useful after the history has already raised a reasonable suspicion of spondyloarthritis. It should support clinical reasoning rather than replace it.
An isolated positive result should not automatically lead to an MRI scan, repeated blood tests or treatment.
What if HLA-B27 is negative?
A negative HLA-B27 result does not exclude axial spondyloarthritis or another form of spondyloarthritis.
HLA-B27 prevalence varies between populations, and a meaningful proportion of people with axial spondyloarthritis are negative. NICE therefore advises clinicians not to rule out the diagnosis solely because HLA-B27 is absent.
A negative result reduces the likelihood of disease in some circumstances, but the history, examination and associated features remain important.
Someone with convincing inflammatory back pain, psoriasis, uveitis, inflammatory bowel disease, enthesitis or dactylitis may still require appropriate assessment despite a negative test.
What if CRP and ESR are normal?
Normal inflammatory markers do not exclude spondyloarthritis.
CRP and ESR can provide supporting evidence when they are elevated, but many people with axial spondyloarthritis have normal results. NICE specifically advises that the diagnosis should not be ruled out because CRP and ESR are normal.
This differs from some other inflammatory conditions in which blood markers may play a more prominent role.
A person should therefore not be reassured solely because HLA-B27, CRP or ESR is negative when the clinical history remains strongly suggestive.
Does a positive HLA-B27 mean that I need an MRI?
Not automatically.
Imaging is useful when the clinical assessment suggests that it may help confirm or clarify the diagnosis. Depending on the circumstances, this may begin with an X-ray of the sacroiliac joints.
X-rays can identify established structural changes but may be normal during earlier disease. MRI can detect active inflammation before definite changes appear on an X-ray, although MRI findings also need careful interpretation.
Mechanical stress, sporting activity, pregnancy-related changes and other non-inflammatory factors can sometimes produce MRI appearances that resemble sacroiliac inflammation. Conversely, a normal MRI does not always settle the diagnosis if clinical suspicion remains high.
The decision to request imaging should therefore be based on the complete clinical picture rather than the HLA-B27 result alone.
What happens after a positive HLA-B27 result?
The next step depends on why the test was requested.
If there are no suggestive symptoms, no treatment or further investigation may be needed. The result may simply be recorded as an incidental inherited finding.
When symptoms are present, assessment usually starts with a detailed history. This includes the age at which back pain began, whether it improves with activity, the presence of night pain or morning stiffness, and any history of psoriasis, eye inflammation, bowel disease, joint swelling, enthesitis or dactylitis.
Examination may assess spinal movement, the sacroiliac region, peripheral joints and tendon insertions. The skin and nails may also provide useful clues.
Blood tests and imaging can then be selected where they are likely to add meaningful information. The purpose is not simply to confirm the blood result. It is to determine whether the overall pattern supports inflammatory disease or whether another explanation is more likely.
A painful red eye requires urgent assessment
HLA-B27 is associated with acute anterior uveitis, which is inflammation inside the front of the eye.
Symptoms can include eye pain, marked redness, sensitivity to light and blurred vision. These symptoms require same-day ophthalmic assessment because untreated uveitis can threaten vision.
A painful, light-sensitive or visually blurred red eye should not wait for a routine rheumatology appointment. It should be assessed urgently through an eye emergency service or another appropriate urgent medical pathway.
When can rheumatology assessment be helpful?
Rheumatology assessment may be appropriate when a positive HLA-B27 occurs alongside persistent back pain with inflammatory features, recurrent joint swelling, unexplained enthesitis or dactylitis.
It can also be useful when there is a history of psoriasis, uveitis or inflammatory bowel disease and the possibility of an associated inflammatory arthritis has not been fully assessed.
The purpose of specialist review is to determine whether the HLA-B27 result fits a coherent inflammatory pattern. Sometimes the outcome is a diagnosis and treatment plan. In other cases, it is reassurance that the marker is incidental and does not currently represent rheumatic disease.
If you have a positive HLA-B27 alongside persistent back pain or other features suggestive of spondyloarthritis, a rheumatology assessment can help determine whether the result is clinically relevant. Information about private rheumatology appointments is available here.
The bottom line
HLA-B27 is an inherited immune-system marker associated particularly with axial spondyloarthritis. A positive result increases the likelihood of disease when the symptoms and associated features fit, but it does not establish a diagnosis.
Most HLA-B27-positive people do not develop inflammatory arthritis. The result does not require treatment, does not normally need repeating and does not mean that healthy relatives should automatically be tested.
Equally, negative HLA-B27, normal inflammatory markers or a normal X-ray do not completely exclude spondyloarthritis.
The important question is not simply whether HLA-B27 is present. It is whether the result fits with the history, examination and wider clinical pattern.
Related reading
Axial Spondyloarthritis Explained: Symptoms, Diagnosis and Treatment
Inflammatory Back Pain: When to Seek Specialist Advice
Inflammatory vs Mechanical Back Pain: Why the Difference Matters
Trusted patient information
NICE: Spondyloarthritis in people over 16
Please note, these posts are for general information only and do not constitute medical advice. Dr Singh would encourage you to speak to your healthcare professional to be assessed and managed for your specific symptoms.